Erythromycin C

Erythromycin C is a lipid of Polyketides (PK) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 35291 references associated with Erythromycin C in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

All references with Erythromycin C

Download all related citations
Per page 10 20 50 100 | Total 7634
Authors Title Published Journal PubMed Link
Esposito S et al. In vitro activity of moxifloxacin compared to other fluoroquinolones against different erythromycin-resistant phenotypes of group A beta-hemolytic streptococcus. 2000 Jan-Feb Chemotherapy pmid:10601794
Polk RE et al. Pharmacokinetic interaction between ketoconazole and amprenavir after single doses in healthy men. 1999 Pharmacotherapy pmid:10600086
Sugiyama Y et al. Effects of long-term administration of erythromycin on cytokine production in rat alveolar macrophages. 1999 Eur. Respir. J. pmid:10596699
Portillo A et al. Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain. 1999 Int. J. Antimicrob. Agents pmid:10595574
Doumith M et al. Interspecies complementation in Saccharopolyspora erythraea : elucidation of the function of oleP1, oleG1 and oleG2 from the oleandomycin biosynthetic gene cluster of Streptomyces antibioticus and generation of new erythromycin derivatives. 1999 Mol. Microbiol. pmid:10594828
Damkier P et al. Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine. 1999 Br J Clin Pharmacol pmid:10594487
Brixius B et al. [Ventricular tachycardia after erythromycin administration in a newborn with congenital AV-block]. 1999 Nov-Dec Klin Padiatr pmid:10592929
Glass D et al. A placebo-controlled clinical trial to compare a gel containing a combination of isotretinoin (0.05%) and erythromycin (2%) with gels containing isotretinoin (0.05%) or erythromycin (2%) alone in the topical treatment of acne vulgaris. 1999 Dermatology (Basel) pmid:10592405
Varaldo PE et al. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group. 1999 Clin. Infect. Dis. pmid:10589905
Durak H et al. Tc-99m erythromycin lactobionate inhalation scintigraphy in parenchymal lung diseases. 1999 Nucl. Med. Biol. pmid:10587109
McCrea J et al. Concurrent administration of the erythromycin breath test (EBT) and oral midazolam as in vivo probes for CYP3A activity. 1999 J Clin Pharmacol pmid:10586386
Zarazaga M et al. In vitro activities of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pediococcus isolates. 1999 Antimicrob. Agents Chemother. pmid:10582908
Klausner MA Astemizole use with erythromycin. 1999 Ann. Allergy Asthma Immunol. pmid:10582723
Brown MS et al. Production of 6-deoxy-13-cyclopropyl-erythromycin B by Saccharopolyspora erythraea NRRL 18643. 1999 J. Antibiot. pmid:10580387
Peng L and Nimni ME Delivery of erythromycin to subcutaneous tissues in rats by means of a trans-phase delivery system. 1999 J. Pharm. Pharmacol. pmid:10579684
Clarke AE et al. Interaction of bile with erythromycin Lactobionate in vitro. 1975 Aust N Z J Med pmid:1057910
Melo-Cristino J and Fernandes ML Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types. Portuguese Surveillance Group for the Study of Respiratory Pathogens. 1999 Microb. Drug Resist. pmid:10566873
Menezes CM et al. In vitro evaluation of erythromycin in chloroquine resistant brazilian P. falciparum freshly isolates: modulating effect and antimalarial activity evidence. 1999 Jul-Aug Rev. Inst. Med. Trop. Sao Paulo pmid:10564920
Matsuoka M et al. Cloning and sequences of inducible and constitutive macrolide resistance genes in Staphylococcus aureus that correspond to an ABC transporter. 1999 FEMS Microbiol. Lett. pmid:10564793
Morel P et al. Clinical efficacy and safety of a topical combination of retinaldehyde 0.1% with erythromycin 4% in acne vulgaris. 1999 Clin. Exp. Dermatol. pmid:10564319
Bauer JF et al. Role of an isomorphic desolvate in dissolution failures of an erythromycin tablet formulation. 1999 J Pharm Sci pmid:10564073
Denis A et al. Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens. 1999 Bioorg. Med. Chem. Lett. pmid:10560728
Reeves AR et al. Transcriptional organization of the erythromycin biosynthetic gene cluster of Saccharopolyspora erythraea. 1999 J. Bacteriol. pmid:10559177
Malonza IM et al. A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya. 1999 J. Infect. Dis. pmid:10558945
Watanabe M et al. Role of CYP3A in bromperidol metabolism in rat in vitro and in vivo. 1999 Xenobiotica pmid:10553724
Jobe DA et al. Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents. 1999 Clin. Diagn. Lab. Immunol. pmid:10548588
Netherwood T et al. Probiotics shown to change bacterial community structure in the avian gastrointestinal tract. 1999 Appl. Environ. Microbiol. pmid:10543832
Aoki Y and Kao PN Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. 1999 Antimicrob. Agents Chemother. pmid:10543746
Maeda K et al. [A case of common variable immunodeficiency that responded to long-term erythromycin chemotherapy]. 1999 Nihon Kokyuki Gakkai Zasshi pmid:10540836
Tobback K et al. Micellar electrokinetic capillary chromatography of macrolide antibiotics. Separation of tylosin, erythromycin and their related substances. 1999 J Chromatogr A pmid:10536850
Schmidtke LM and Carson J Induction, characterisation and pathogenicity in rainbow trout Oncorhynchus mykiss (Walbaum) of Lactococcus garvieae L-forms. 1999 Vet. Microbiol. pmid:10535774
Janier M [Syphilis (except congenital syphilis)]. 1999 Aug-Sep Ann Dermatol Venereol pmid:10530355
Sato A et al. Effects of organic anions and vinblastine on biliary excretion of erythromycin in rats. 1999 Pharmacology pmid:10529657
Yoh M et al. Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7. 1999 Can. J. Microbiol. pmid:10526400
Shortridge VD et al. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995. 1999 Clin. Infect. Dis. pmid:10524961
Xue Q et al. A multiplasmid approach to preparing large libraries of polyketides. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10518520
De Winter BY et al. Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats. 1999 Gut pmid:10517907
Ball SE et al. Population distribution and effects on drug metabolism of a genetic variant in the 5' promoter region of CYP3A4. 1999 Clin. Pharmacol. Ther. pmid:10511065
Kinirons MT et al. Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A. 1999 Clin. Pharmacol. Ther. pmid:10511057
McMullin ST et al. Impact of a Web-based clinical information system on cisapride drug interactions and patient safety. 1999 Arch. Intern. Med. pmid:10510994
Khan SA et al. Simultaneous detection of erythromycin-resistant methylase genes ermA and ermC from Staphylococcus spp. by multiplex-PCR. 1999 Mol. Cell. Probes pmid:10508560
Oster P et al. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. 1999 Antimicrob. Agents Chemother. pmid:10508033
Miossec-Bartoli C et al. The new ketolide HMR3647 accumulates in the azurophil granules of human polymorphonuclear cells. 1999 Antimicrob. Agents Chemother. pmid:10508024
Rosendal K et al. Staphylococcus aureus strains isolated in Danish hospitals from January 1st, 1966, to December 31st, 1974. 1976 Acta Pathol Microbiol Scand B pmid:1050144
Moreno M et al. Clinical management of tacrolimus drug interactions in renal transplant patients. 1999 Transplant. Proc. pmid:10500564
Zgoulli S et al. Microencapsulation of erythromycin and clarithromycin using a spray-drying technique. 1999 Sep-Oct J Microencapsul pmid:10499837
Gibson EM et al. Transfer of plasmid-mediated antibiotic resistance from streptococci to lactobacilli. 1979 J. Bacteriol. pmid:104973
Cash P et al. A proteomic analysis of erythromycin resistance in Streptococcus pneumoniae. 1999 Electrophoresis pmid:10493130
Moore PA Dental therapeutic indications for the newer long-acting macrolide antibiotics. 1999 J Am Dent Assoc pmid:10492541
Gómez-Lus R et al. Is there an ecological relationship between rates of antibiotic resistance of species of the genus Streptococcus? The Spanish Surveillance Group for Respiratory Pathogens. 1999 J. Clin. Microbiol. pmid:10488213

Table of Content